EDGAR Filing Documents for 0001104659-21-126794

Form 8-K - Current report:

SEC Accession No. 0001104659-21-126794

Filing Date

2021-10-15

Accepted

2021-10-15 17:03:27

Documents

Period of Report

2021-10-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2130098d1_8k.htm iXBRL	8-K	36476
2	EXHIBIT 4.1	tm2130098d1_ex4-1.htm	EX-4.1	104500
3	EXHIBIT 5.1	tm2130098d1_ex5-1.htm	EX-5.1	9921
4	EXHIBIT 10.1	tm2130098d1_ex10-1.htm	EX-10.1	207469
5	EXHIBIT 99.1	tm2130098d1_ex99-1.htm	EX-99.1	9683
	Complete submission text file	0001104659-21-126794.txt		630426

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	ptpi-20211013.xsd	EX-101.SCH	3201
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ptpi-20211013_lab.xml	EX-101.LAB	34594
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ptpi-20211013_pre.xml	EX-101.PRE	22721
9	EXTRACTED XBRL INSTANCE DOCUMENT	tm2130098d1_8k_htm.xml	XML	3734

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005

Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)